MetLife Investment Management, LLC - SIENNA BIOPHARMACEUTICALS IN ownership

SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 52 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of SIENNA BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$147,0007,8060.00%
Other shareholders

There were no reported owners of SIENNA BIOPHARMACEUTICALS IN in Q1 2018.

NameSharesValueWeighting ↓
View complete list of SIENNA BIOPHARMACEUTICALS IN shareholders